148 related articles for article (PubMed ID: 34974289)
1. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
[TBL] [Abstract][Full Text] [Related]
2. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia.
Li Y; Schwab C; Ryan S; Papaemmanuil E; Robinson HM; Jacobs P; Moorman AV; Dyer S; Borrow J; Griffiths M; Heerema NA; Carroll AJ; Talley P; Bown N; Telford N; Ross FM; Gaunt L; McNally RJQ; Young BD; Sinclair P; Rand V; Teixeira MR; Joseph O; Robinson B; Maddison M; Dastugue N; Vandenberghe P; Stephens PJ; Cheng J; Van Loo P; Stratton MR; Campbell PJ; Harrison CJ
Nature; 2014 Apr; 508(7494):98-102. PubMed ID: 24670643
[TBL] [Abstract][Full Text] [Related]
3. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia.
Harrison CJ; Schwab C
Eur J Med Genet; 2016 Mar; 59(3):162-5. PubMed ID: 26836400
[TBL] [Abstract][Full Text] [Related]
4. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
[TBL] [Abstract][Full Text] [Related]
5. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21.
Verdoni AM; Zilla ML; Bullock G; Guinipero TL; Meade J; Yatsenko SA
Am J Med Genet A; 2022 Aug; 188(8):2325-2330. PubMed ID: 35678493
[TBL] [Abstract][Full Text] [Related]
6. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.
Harrison CJ
Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of iAMP21 and
Gu J; Reynolds A; Fang L; DeGraffenreid C; Sterns K; Patel KP; Medeiros LJ; Lin P; Lu X
Mol Cytogenet; 2016; 9():84. PubMed ID: 27895713
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
[TBL] [Abstract][Full Text] [Related]
9. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
[TBL] [Abstract][Full Text] [Related]
10. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract][Full Text] [Related]
11. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.
Harrison CJ; Moorman AV; Schwab C; Carroll AJ; Raetz EA; Devidas M; Strehl S; Nebral K; Harbott J; Teigler-Schlegel A; Zimmerman M; Dastuge N; Baruchel A; Soulier J; Auclerc MF; Attarbaschi A; Mann G; Stark B; Cazzaniga G; Chilton L; Vandenberghe P; Forestier E; Haltrich I; Raimondi SC; Parihar M; Bourquin JP; Tchinda J; Haferlach C; Vora A; Hunger SP; Heerema NA; Haas OA;
Leukemia; 2014 May; 28(5):1015-21. PubMed ID: 24166298
[TBL] [Abstract][Full Text] [Related]
12. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
Tsuchiya KD; Davis B; Gardner RA
Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
[TBL] [Abstract][Full Text] [Related]
13. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
[TBL] [Abstract][Full Text] [Related]
14. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
[TBL] [Abstract][Full Text] [Related]
15. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB
Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717
[TBL] [Abstract][Full Text] [Related]
16. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle.
Robinson HM; Harrison CJ; Moorman AV; Chudoba I; Strefford JC
Genes Chromosomes Cancer; 2007 Apr; 46(4):318-26. PubMed ID: 17243167
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
[TBL] [Abstract][Full Text] [Related]
18. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Strefford JC; van Delft FW; Robinson HM; Worley H; Yiannikouris O; Selzer R; Richmond T; Hann I; Bellotti T; Raghavan M; Young BD; Saha V; Harrison CJ
Proc Natl Acad Sci U S A; 2006 May; 103(21):8167-72. PubMed ID: 16702559
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
[TBL] [Abstract][Full Text] [Related]
20. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ
J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
